Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Cardiac risk factors and the use of triptans: A survey study
Autore:
Young, WB; Mannix, L; Adelman, JU; Shechter, AL;
Indirizzi:
Thomas Jefferson Univ Hosp, Jefferson Headache Ctr, Philadelphia, PA 19107USA Thomas Jefferson Univ Hosp Philadelphia PA USA 19107 delphia, PA 19107USA Headache Wellness Ctr, Greensboro, NC USA Headache Wellness Ctr Greensboro NC USA Wellness Ctr, Greensboro, NC USA
Titolo Testata:
HEADACHE
fascicolo: 7, volume: 40, anno: 2000,
pagine: 587 - 591
SICI:
0017-8748(200007/08)40:7<587:CRFATU>2.0.ZU;2-M
Fonte:
ISI
Lingua:
ENG
Soggetto:
SUMATRIPTAN;
Keywords:
cardiac risk factors; dihydroergotamine; migraine; myocardial infarction; triptans;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
6
Recensione:
Indirizzi per estratti:
Indirizzo: Young, WB Thomas Jefferson Univ Hosp, Jefferson Headache Ctr, 111 S 11th St,Gibbon Bldg,Suite 8130, Philadelphia, PA 19107 USA Thomas Jefferson Univ Hosp 111 S 11th St,Gibbon Bldg,Suite 8130 Philadelphia PA USA 19107
Citazione:
W.B. Young et al., "Cardiac risk factors and the use of triptans: A survey study", HEADACHE, 40(7), 2000, pp. 587-591

Abstract

Objective.-To describe current practice in triptan use. Background.-Triptans are effective migraine treatments that cause chest symptoms in some patients. True cardiac ischemia is rare. Design.-Headache specialists and family practitioners completed questionnaires regarding the times when triptans are contraindicated, obtaining electrocardiograms (ECGs), and giving the first dose in the office. Results.-Sixty-five headache specialists and 67 family practitioners responded. Headache specialists saw an average of 36.3 patients with headache per week. Family practitioners saw an average of 7.2. Family practitioners and headache specialists had similar opinions regarding the age at which triptans were contraindicated with various numbers of risk factors. Sixty-one percent of headache specialists and 50% of family practitioners would not use a triptan at any age for patients with more than three risk factors (P=NS). Ten percent of headache specialists obtained an ECG for all patients being prescribed triptans, while no family practitioners did (P=.008). Ten percent ofboth family practitioners and headache specialists never obtained an EGG, even with multiple cardiac risk factors. Headache specialists obtained ECGsmore often than family practitioners (P<.002 for one to three risk factors). Family practitioners were more likely to give the first dose of the triptan in the office regardless of cardiovascular risk (58% versus 20%, P<.001). Forty-five percent of headache specialists and 2% of family practitioners never gave the first dose in the office (P<.001). Family practitioners gave the first dose in the office more readily than headache specialists in patients with no risk factors (P=.001), but not for one or more risk factors. Conclusions.-No consensus exists among family practitioners or headache specialists about when to avoid using a triptan due to excessive cardiac riskfactors, when to obtain an ECG prior to using a triptan, and when to give the first dose of a triptan in the office. Headache specialists are more likely to obtain ECGs, whereas family practitioners are more likely to give the first dose of a triptan in the office.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/09/20 alle ore 16:50:07